347682 RESULTS
MUTATIONS APP 27269971 GRCh37/hg19 rs770773038 A T 25897659 GRCh38/hg38 A T Exon 16 Coding Unknown, but predicted deleterious in silico (PHRED-scaled CADD score = 25.8). Unknown. N660Y Alzheimer's Disease: Not ClassifiedProbable VaD Data on the carrier(s) of t
PAPER Coleman MP, Höke A
PAPER Sambashivan S, Freeman MR
JOB 2025-03-07 Employer AlzForum Foundation Inc. Contact Apply here. Description The biocuration scientist is responsible for the ongoing curation of scientific databases and directories in the Alzforum website (www.alzforum.org). Alzforum provides a high-quality scien
THERAPEUTICS Nura Bio™ Inc. Small Molecule Other In August 2023, Nura Bio began Phase 1 with an ascending-dose safety trial in 66 healthy volunteers. Single doses of 50, 100, 175, 300, 450, and 600 mg, or 10 days of repeated dosing were compared to placebo. Besides sa
COMMENT A PET ligand that reveals oxidative stress in the human brain will facilitate work within the AD research field on a number of levels. It will help investigators get a glimpse into oxidative stress in the brains of AD patients. From there, investigators c
, United Kingdom
PAPER Wen S, Ju Z, Wang Y, Zuo CT, Sun X, Zheng T
PAPER Ludolph A, Klose V, Dreyhaupt J, Del Tredici K, Braak H
PAPER Al-Kuraishy HM, Sulaiman GM, Mohammed HA, Al-Gareeb AI, Albuhadily AK, Mohammed SG
PAPER Preziuso A, Serfilippi T, Toujani M, Terenzi V, Amoroso S, Magi S, Lariccia V, Piccirillo S
PAPER Qiang Q, Skudder-Hill L, Toyota T, Huang Z, Wei W, Adachi H, Alzheimer’s Disease Neuroimaging Initiative
PAPER Pikija S, Toma A, Radlberger R, Griessenauer CJ, Hecker C, Trinka E, Ki PH, Kraus T, Weis S, Wermer MJ, van Etten ES, Kaushik K
PAPER Alpaugh M, Lantero-Rodriguez J, Benedet AL, Manseau U, Boutin M, Maiuri M, Denis HL, Masnata M, Fazal SV, Chouinard S, Rosa-Neto P, Barker RA, Blennow K, Zetterberg H, Labib R, Cicchetti F
PAPER Wang Z, Cheng C, Duan H, Chen X, Li W, Ma F, Li Z, Yan J, He R, Li Z, Yang M, Huang Z, Chen Y, Huang G
